Baird Medical Investment Holdings Ltd (BDMD) Earnings Signals & AI Vibe Check

Latest Filing: 20-F  |  Filed Apr 24, 2026

Cross-checked across multiple AI analysts and grounded in the latest SEC filing.

powered by: earningsVibe.ai

Question:
What is the latest filing signal for Baird Medical Investment Holdings Ltd?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest 20-F, Baird Medical Investment Holdings Ltd's filing signal turned negative.
earningsVibe SuperAnalyst™ Verdict: TURNED NEGATIVE

Signal Performance — Stock Price Since Filing

30-Day Change
-14.13%
from filing date
60-Day Change
Pending
from filing date

Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT

PERPLEXITY
Turned Negative
GEMINI
Turned Negative
CLAUDE
Turned Negative
CHATGPT
Turned Negative

Unlock the Full Filing Analysis

See full earningsSig™ and risksSig™ analysis across 5,000+ companies

Get Started Free →

No credit card required

Question:
What does Baird Medical Investment Holdings Ltd actually do?
Answer:
Baird Medical Investment Holdings Limited is a specialized healthcare innovator focused on thyroid-related diseases, aiming to transform treatment through intelligent, non-invasive solutions. The company develops and commercializes microwave ablation systems and is advancing AI-integrated robotic systems for thyroid care. It ranks as a leading provider of microwave ablation medical devices in China, holding the top position in sales revenue and volume for microwave ablation needles in thyroid nodule and breast lump treatments in 2022. Baird Medical's business model encompasses the design, development, manufacturing, and sale of its proprietary microwave ablation medical devices, with sales primarily driven by microwave ablation needles and therapeutic apparatuses. The company operates through direct sales, deliverers, and distributors, serving hospitals across China.
Question:
What are Baird Medical Investment Holdings Ltd's revenue drivers?
Answer:
Revenue is primarily driven by the sales of proprietary microwave ablation medical devices, specifically microwave ablation needles and therapeutic apparatuses. Sales of other medical devices contributed a small portion of revenue in 2023 but were negligible in subsequent years.

Cut through noisy SEC filings to find the signal faster

Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.

Get Started Free →

No credit card required